Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synovus Financial Turns To Profit In Q1 Vs Loss Last Year - Quick Facts

RELATED NEWS
Trade SNV now with 

Synovus Financial Corp. (SNV: Quote) reported net profit available to common shareholders for the first quarter of 2012 of $21.40 million or $0.024 per share versus loss of $93.70 million or $0.119 loss per diluted share reported for the corresponding first quarter of 2011.

On average, 21 analysts polled by Thomson Reuters expected the company to report $0.01 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the first quarter of 2012 declined to $220.96 million from $237.43 million in the corresponding quarter last year.

Total non-interest income, however, increased to $84.14 million from $64.16 million a year ago. Analysts estimated revenues of $287.10 million.

Click here to receive FREE breaking news email alerts for Synovus Financial and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.